Monday, August 31, 2026 SourcesAbout🌓
🇨🇦 CA ▾
BREAKING
Business

Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update

Financial Post ·

VANCOUVER, British Columbia, Aug.

31, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and “YTD 2026”, respectively), and provided an update on recent corporate developments.

Read More

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

More in Business

See all ›